Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Stoter

Showing results (81-90 of 249) with videos related to

Pageof 25
Sort By:
International Journal of Cancer|February 8, 1995
Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytesC H Lamers, J W Gratama, S O Warnaar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary siteA van der Gaast, J Verweij, A S Planting, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Vindesine in advanced renal cancer. A study of the EORTC Genito-urinary Tract Cancer Cooperative GroupS D Fosså, L Denis, A T van Oosterom, et al.
International Journal of Cancer|October 23, 1997
Local but no systemic immunomodulation by intraperitoneal treatment of advanced ovarian cancer with autologous T lymphocytes re-targeted by a bi-specific monoclonal antibodyC H Lamers, R L Bolhuis, S O Warnaar, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1992
Phase I study of intravenous fosquidone (GR63178A-NSC D611615) using a three times a week scheduleA S Planting, M E van der Burg, G Stoter, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 21, 1997
Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detectionP de Bruijn, J Verweij, W J Loos, et al.
British Journal of Cancer|January 1, 1997
Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical developmentC J Gerrits, M J de Jonge, J H Schellens, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 14, 1998
Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detectionA Sparreboom, P de Bruijn, K Nooter, et al.
The Netherlands Journal of Medicine|January 1, 1985
Pulmonary tumour embolism in a case of adenoid cystic carcinomaA J Nielander, G Stoter, W S Kwee, et al.
European Journal of Clinical Investigation|April 12, 2000
Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein responseT C Stam, A J Swaak, W H Kruit, et al.
Pageof 25

Showing results (81-90 of 249) with videos related to

Sort By:
Pageof 25
International Journal of Cancer|February 8, 1995
Inhibition of bispecific monoclonal antibody (bsAb)-targeted cytolysis by human anti-mouse antibodies in ovarian carcinoma patients treated with bsAb-targeted activated T-lymphocytesC H Lamers, J W Gratama, S O Warnaar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 1995
Simple prognostic model to predict survival in patients with undifferentiated carcinoma of unknown primary siteA van der Gaast, J Verweij, A S Planting, et al.
European Journal of Cancer & Clinical Oncology|April 1, 1983
Vindesine in advanced renal cancer. A study of the EORTC Genito-urinary Tract Cancer Cooperative GroupS D Fosså, L Denis, A T van Oosterom, et al.
International Journal of Cancer|October 23, 1997
Local but no systemic immunomodulation by intraperitoneal treatment of advanced ovarian cancer with autologous T lymphocytes re-targeted by a bi-specific monoclonal antibodyC H Lamers, R L Bolhuis, S O Warnaar, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|May 1, 1992
Phase I study of intravenous fosquidone (GR63178A-NSC D611615) using a three times a week scheduleA S Planting, M E van der Burg, G Stoter, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|November 21, 1997
Determination of irinotecan (CPT-11) and its active metabolite SN-38 in human plasma by reversed-phase high-performance liquid chromatography with fluorescence detectionP de Bruijn, J Verweij, W J Loos, et al.
British Journal of Cancer|January 1, 1997
Topoisomerase I inhibitors: the relevance of prolonged exposure for present clinical developmentC J Gerrits, M J de Jonge, J H Schellens, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|March 14, 1998
Determination of paclitaxel in human plasma using single solvent extraction prior to isocratic reversed-phase high-performance liquid chromatography with ultraviolet detectionA Sparreboom, P de Bruijn, K Nooter, et al.
The Netherlands Journal of Medicine|January 1, 1985
Pulmonary tumour embolism in a case of adenoid cystic carcinomaA J Nielander, G Stoter, W S Kwee, et al.
European Journal of Clinical Investigation|April 12, 2000
Intrapleural administration of tumour necrosis factor-alpha (TNFalpha) in patients with mesothelioma: cytokine patterns and acute-phase protein responseT C Stam, A J Swaak, W H Kruit, et al.
Pageof 25